QLGN icon

Qualigen Therapeutics
QLGN

Overview Fund Trends Analyst Outlook Journalist POV

7 hedge funds and large institutions have $114K invested in Qualigen Therapeutics in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

53% less capital invested

Capital invested by funds: $242K → $114K (-$128K)

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$718K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$12.5K
2
+$8K
3
+$6.43K
4
TSS
Two Sigma Securities
New York
+$5K
5
HF
HRT Financial
New York
+$4K

Top Sellers

1
-$87K
2
-$7K
3
-$2.12K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$55K
2
$25K
3
$15K
4
$8K
5
$5K
6
$4K
7
$2K
8
–
9
–